İçeriğe geç
akaturk Akademik ölçüm
Akademik özet YÖKSİS ve OpenAlex ayrı sayılır.
Makale 49
YÖKSİS49 OpenAlex0
Proje 13
Kitap 2
Bildiri 28

Atıf etkisi

OpenAlex YÖKSİS makalelerinden OpenAlex’te eşleşen: 46
h-indeks 23 Türkiye yüzdelik dilimi: 98 Üniversitesinde h-indekse göre 30. / 1.449
i10-indeks
29
Toplam atıf
1.500
Türkiye’de üst %2,5
Makale başına
32,6
FWCI
2,38
1,00 = dünya ortalaması
Dünyada üst %1
0
Dünyada üst %10
18

h-indeks ve atıflar, bu akademisyenin YÖKSİS makalelerinden OpenAlex’te eşleşenlerin atıf sayılarından hesaplanır (Google Scholar, WoS veya Scopus değildir). Eşleşmeyen makalelerin atıfı dahil değildir.

Alan sıralaması

YÖKSİS ?

Dizin çeyrekleri

?
Scopus (SJR) 47
  • Q1 11
  • Q2 23
  • Q3 8
  • Q4 5
WoS (JCR) 44
  • Q1 21
  • Q2 5
  • Q3 10
  • Q4 8
TR Index TR Index

3 makale

OpenAlex atıf yüzdelik
  • Üst %1 0
  • Üst %10 18
  • Ort. 75.4%
  • n 46
Diğer sayımlar

Scopus (SJR)

  • YÖKSİS satırı 47

WoS (JCR)

  • YÖKSİS satırı 44

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Yayını olan dergiler

26 dergi

Makale listesi

  1. 2026 Design, synthesis and QSAR-based antitumor signaling pathway analysis of pyrazoline- benzenesulfonamides mediated by cytostatic G1 arrest Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.143792 YÖKSİS SJR Q2 JCR Q2 OpenAlex 10.9%
  2. 2026 Potential of Time Domain Nuclear Magnetic Resonance as a Noninvasive Method for Detection and Quantification of Protein Glycation in Biopharmaceuticals Analytical Chemistry DOI 10.1021/acs.analchem.5c07921 YÖKSİS SJR Q1 JCR Q1 OpenAlex 14.6%
  3. 2026 Indole‐Chalcone‐Sulfonamide Hybrids: Synthesis and Dual Biological Evaluation as Anticancer and Antioxidant Agents Chemistry Select DOI 10.1002/slct.202503713 YÖKSİS SJR Q3 JCR Q3 OpenAlex üst %10 OpenAlex 96.4%
  4. 2025 Synthesis, Bioactivities, and in Silico Studies of Novel Benzo[d][1,3]Dioxole-Based Pyrazoline Sulfonamides Polycyclic Aromatic Compounds DOI 10.1080/10406638.2025.2498144 YÖKSİS SJR Q3 JCR Q2 OpenAlex 76.5%
  5. 2025 Pharmaceutical Studies on Piperazine-based Compounds Targeting Serotonin Receptors and Serotonin Reuptake Transporters Mini-Reviews in Medicinal Chemistry DOI 10.2174/0113895575319878240612070850 YÖKSİS SJR Q2 JCR Q2 OpenAlex 77.7%
  6. 2025 Non-invasive detection of protein aggregation in biopharmaceuticals using TD-NMR and MRI European Journal of Pharmaceutics and Biopharmaceutics DOI 10.1016/j.ejpb.2025.114830 YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.8%
  7. 2024 In Vitro Enzyme Activity and Molecular Docking Studies of Pyrazoline Derivatives as Monoamine Oxidase Inhibitors Pharmaceutical Chemistry Journal DOI 10.1007/s11094-024-03161-7 YÖKSİS SJR Q4 JCR Q4 OpenAlex 42.0%
  8. 2024 Biological Activities and Drug-Likeness Properties of Phenol-Based Heterocyclic Compounds Pharmaceutical Chemistry Journal DOI 10.1007/s11094-024-03076-3 YÖKSİS SJR Q4 JCR Q4 OpenAlex 71.9%
  9. 2024 Design, synthesis, biological evaluation and docking analysis of pyrrolidine-benzenesulfonamides as carbonic anhydrase or acetylcholinesterase inhibitors and antimicrobial agents Journal of Biomolecular Structure and Dynamics DOI 10.1080/07391102.2023.2214224 YÖKSİS SJR Q2 JCR Q3 OpenAlex 87.3%
  10. 2024 Synergistic quantification of mixed insulin preparations using time domain NMR techniques Journal of Pharmaceutical and Biomedical Analysis DOI 10.1016/j.jpba.2024.116260 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 91.5%
  11. 2023 Design, synthesis, and assessment of pharmacological properties of indole-based fluorinated chalcones and their benzenesulfonamide analogs CHEMICAL PAPERS DOI 10.1007/s11696-023-03060-3 YÖKSİS SJR Q2 JCR Q3 OpenAlex 80.4%
  12. 2023 Recent developments in tacrine-based hybrids as a therapeutic option for Alzheimer’s disease Mini-Reviews in Medicinal Chemistry DOI 10.2174/1389557523666221201145141 YÖKSİS SJR Q2 JCR Q3 OpenAlex 76.5%
  13. 2023 N-Benzoylthiourea-pyrrolidine carboxylic acid derivatives bearing an imidazole moiety: Synthesis, characterization, crystal structure, in vitro ChEs inhibition, and antituberculosis, antibacterial, antifungal studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2022.134303 YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 90.4%
  14. 2023 Current Pharmaceutical Research on the Significant Pharmacophore Mannich bases in Drug Design Bentham Science Publishers Ltd. DOI 10.2174/0115680266256102230922101939 YÖKSİS SJR Q2 JCR Q3 OpenAlex 76.9%
  15. 2023 IMIDAZOLINONE-BASED SULFONAMIDE DERIVATIVES: SYNTHESIS, CHARACTERIZATION, AND INHIBITORY PROPERTY AGAINST SOME METABOLIC ENZYMES Ankara Universitesi Eczacilik Fakultesi Dergisi DOI 10.33483/jfpau.1311157 YÖKSİS SJR Q3 OpenAlex 39.2%
  16. 2023 Molecular docking studies and biological activities of benzenesulfonamide-based thiourea and thiazolidinone derivatives targeting cholinesterases, α-glucosidase, and α-amylase enzymes The Turkish Chemical Society DOI 10.18596/jotcsa.1111172 YÖKSİS OpenAlex 72.2%
  17. 2022 Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies Bioorganic Chemistry DOI 10.1016/j.bioorg.2022.105822 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 97.4%
  18. 2022 Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores Bioorganic Chemistry DOI 10.1016/j.bioorg.2022.105969 YÖKSİS SJR Q1 JCR Q1 OpenAlex 82.8%
  19. 2021 Effects of a Novel Benzenesulfonamide 4-(3-(4-Bromophenyl)-5-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl) on Antioxidant Enzymes and Hematological Parameters of Rainbow Trout (Oncorhynchus mykiss) Pakistan Journal of Zoology DOI 10.17582/journal.pjz/20191118081134 YÖKSİS SJR Q4 JCR Q4 OpenAlex 46.0%
  20. 2021 Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides European Journal of Medicinal Chemistry DOI 10.1016/j.ejmech.2021.113351 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.7%

Akademisyenlere dön